Dr Reddys Labs Consolidated December 2024 Net Sales at Rs 8,381.20 crore, up 15.81% Y-o-Y Jan 28 2025 01:32 PM Hold Dr Reddys Laboratories; target of Rs 1245: KR Choksey Jan 27 2025 12:36 PM ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

After hours: January 29 at 6:02:40 PM EST Loading Chart for IDXX ...

After hours: January 30 at 4:01:42 PM EST Loading Chart for MLAB ...

For example, in HZNP Medicines LLC, Horizon Pharma USA, Inc. v. Actavis Laboratories UT, Inc., 940 F.3d 680, 702 (Fed. Cir. 2019), the claim at issue required the three steps of (1) applying the ...

This comes nine years after the company made bold moves overseas as it acquired Actavis’ UK and Actavis Ireland businesses from Teva Pharmaceutical Industries Ltd for around $769 million. VCCircle ...

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 31,732.31 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...

Two of the most notable examples of this in recent years are Actavis (now owner of Allergan and to take Allergan's name globally) and Gilead. Actavis was a generics giant whose rise mirrors the ...

Lambda Labs, a Nvidia partner, has lost its chief operating officer to a little-known company building hardware for the AI industry. Mitesh Agrawal told Business Insider he stepped into a new role ...

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...